Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine (Q80422012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Cooper CL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Davis HL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Morris ML

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Efler SM

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Krieg AM

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Li Y

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Laframboise C

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Al Adhami MJ

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Khaliq Y

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Seguin I

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

23-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

3136-3143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

CpG motifs in bacterial DNA trigger direct B-cell activation

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

CpG motifs: the active ingredient in bacterial extracts?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Influenza vaccines. A reappraisal of their use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Antigenic drift and efficacy of influenza virus vaccines, 1976--1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Prevention and control of influenza. Role of vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

The immunogenicity of influenza virus vaccine in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Adhesion-mediated enhancement of the adjuvant activity of alum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Temperature-Sensitive Mutants of Influenza Virus. IV. Induction of Interferon in the Nasopharynx by Wild-Type and a Temperature-Sensitive Recombinant Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Production of Interferon in Volunteers Infected with Asian Influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

inferred from DOI database lookup

7 January 2021

based on heuristic

Biological activities of immunoglobulins of different classes and subclasses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.058

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.01.058

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297066%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference